International Patent: ANTIBODY-DRUG CONJUGATE, STEREOISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

GENEVA, Oct. 30 -- CHINA ONCOLOGY FOCUS LIMITED filed a patent application (CN2025/141727) for “ANTIBODY-DRUG CONJUGATE, STEREOISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF”. With publication no. WO/2026/223088, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....